The molecular mechanisms underlying synaptic exocytosis in the hair cell, the auditory and vestibular receptor cell, are not well understood. Otoferlin, a C2-domain-containing Ca 2+ binding protein, has been implicated as having a role in vesicular release. Mutations in the OTOF gene cause non-syndromic deafness in humans, and OTOF knockout mice are deaf. In the present study, we generated otoferlin fusion proteins containing two of the same amino acid substitutions detected in DFNB9 patients (Pro1825Ala in C2F and Leu1011Pro in C2D). The native otoferlin C2F domain bound syntaxin 1A and SNAP-25 in a Ca 2+ -dependent manner (with optimal 61 µM free Ca 2+ required for binding). These interactions were greatly diminished for C2F with the Pro1825Ala mutation, possibly due to a reduction in tertiary structural change, induced by Ca 2+ , for the mutated C2F compared to the native C2F. The otoferlin C2D domain also bound syntaxin 1A, but with weaker affinity (K D = 1.7 x 10 -5 M) than for the C2F interaction (K D = 2.6 x 10 -9 M). In contrast, it was the otoferlin C2D domain that bound the Ca v 1.3 II-III loop, in a Ca 2+ -dependent manner. The Leu1011Pro mutation in C2D rendered this binding insensitive to Ca 2+ and considerably diminished. Overall, we demonstrated that otoferlin interacts with two main target-SNARE proteins of the hair-cell synaptic complex, syntaxin 1A and SNAP-25, as well as the calcium channel, with the otoferlin C2F and C2D domains of central importance for binding. Since mutations in the otoferlin C2 domains that cause deafness in humans impair otoferlin's ability to bind syntaxin, SNAP-25, and the Ca v 1.3 calcium channel, it is these interactions that may mediate regulation by otoferlin of hair cell synaptic exocytosis critical to inner-ear hair-cell function.
cells, calcium micro-domains (2) and possibly nanodomains (3) are formed when voltage-gated calcium channels (VGCC) open upon depolarization. Calcium at these sites is thought to activate protein interactions, leading to vesicle fusion. Some of the key players in this process are the target-SNARE proteins, syntaxin 1A and SNAP-25, and the vesicle-SNARE, synaptobrevin (4) . Vesicle-SNARE synaptotagmin 1 plays a crucial role as a calcium sensor at the neuronal synapse, modulating calcium channels and vesicle release by a Ca 2+ -dependent interaction with other SNARE proteins in the presence of lipid molecules (4, 5, 6) . However, in vertebrate mechanosensory hair cells, synaptotagmin 1 is not detected (7) . Instead, fast neurotransmitter release in auditory and vestibular hair cells, facilitated largely by an L-type voltagegated calcium channel, Ca v 1.3 (8, 9) , is thought to be modulated by a newly discovered protein, otoferlin, acting as the Ca 2+ sensor and vesicle binding protein. When mutated, otoferlin causes DFNB9 non-syndromic deafness (10) . Gene sequences of different deaf families show that the OTOF gene can undergo mutation at multiple locations (11, 12, 13) . Recently, it has been demonstrated that otoferlin is necessary for synaptic exocytosis from hair cells (14) . Further, an engineered mutation in the C2B domain of otoferlin has been shown to cause deafness in mice (15) . However, the precise function of otoferlin as a synaptic protein is not well understood.
Specific mutations in the otoferlin C2F (Pro1825Ala) or C2D (Leu1011Pro) domains in humans have been documented to cause DFNB9 deafness (11, 12) . Previous studies suggested that a region of otoferlin containing all three C2 domains, D, E, and F, bind directly to the t-SNARE molecules syntaxin 1A and SNAP-25 in response to an increase in Ca 2+ concentration (14) . However, it is not understood how a single amino acid substitution in one domain of otoferlin, such as C2F (11) or C2D (12) , might independently lead to deafness. Here, we examine the role of otoferlin as a Ca sensor as well as a facilitator of vesicle fusion, as indicated by protein-protein interactions and their [Ca 2+ ] dependence.
EXPERIMENTAL PROCEDURES
Materials − Plasmids for hexahistidine-tagged fusion proteins, pRSET A, B, and C, and antiXpress antibody (raised against the sequence DLYDDDDK) were obtained from Invitrogen (Carlsbad, CA, USA). Glutathione-S-transferase (GST) fusion plasmid pGEX-6P-1 and HBS-E, HBS-P, and HBS-EP buffers for surface plasmon resonance (SPR) analysis were from GE HealthcareAmersham (Piscataway, NJ, USA). Yeast twohybrid plasmids, pGBKT7 and pGADT7, and mouse brain cDNA, were from BD-BiosciencesClontech (Palo Alto, CA, USA). Anti-His tag monoclonal antibody (recognizing polyhistidine sequences), anti-GST antibody (against Schistosoma japonicum GST sequence), anti-syntaxin antibody, phosphate-buffered saline (PBS), and PBST buffer were from Sigma-Aldrich, St. Louis, MO, USA.
Cloning of Otoferlin C2 Domains, Syntaxin 1A, SNAP-25, and Ca v 1.3 II-III Loop in pRSET Vectors
− PCR primers for otoferlin C2 domains, syntaxin 1A (minus the transmembrane region), SNAP-25, and the Ca v 1.3 II-III loop, containing desired restriction sites, were designed from mouse cDNA sequence (GenBank NM_031875, NM_016801, M22012, and NM_028981, respectively), customsynthesized, and used in PCR reactions containing mouse brain cDNA as template (BD-BiosciencesClontech). PCR products were digested with restriction enzymes and cloned into similarlydigested pRSET bacterial expression vectors (Invitrogen). The plasmids were prepared in E. coli DH5α cells (Invitrogen). Selected clones were sequence-verified before expression studies. Primers used for PCR (upstream, downstream) were:  otoferlin  C2A:  TCTAGAATTCATGGCCCTGATTGTTCAC,  GGATCCTAGCAGCCCATCTGTCTC; otoferlin  C2B:  TCTAGAATTCGACCCTGACTCCGTGTCT,  GGATCCCACAGCGACATCACACTT; otoferlin  C2C:  TCTAGAATTCCGGTTCTATGTGAAAATTTAC,  GGATCCGCCGTACATGTTCACCCA; otoferlin  C2D:  TCTAGAATTCGCCAAGCTGGAGCTCTAC,  GGATCCCAGCTCGAAGGCAGCCAG; otoferlin  C2E:  TCTAGAATTCCGCATAGTAGGCCGATTC,  GGATCCCCCATGGGGACCAAAGTG; otoferlin   C2F:  TCTAGAATTCCCGCTGCTCAACCCTGAC,  GGATCCGGGCCACCAGCCTTTGAC; syntaxin  1A:  ATGGAGGACCGAACCCAGGAG,  CTACTTCTTCCTGCGCGC;  SNAP-25:  AGGATCCGATGGCCGAGGACGCAGACATGG  ,  TCGAATTCTTAACCACTTCCCAGGATCTTTG;  and  the  Ca v 1.3  II-III  loop:  TCAGAATTCGTGGACAATTTGGCTGAT,  GGATCCAAGGTTGGTGAAGATGTG. C2 Domain Mutations − Mutations within the otoferlin C2 domains were generated in vitro in two steps by oligonucleotide-directed mutagenesis. The upstream and downstream mutated primers were: otoferlin C2D: TGGGACCAGATGCCGGTATTTGAC, GTTGTCAAATACCGGCATCTGGTC (underlined nucleotides yield Pro, CCG, substituting for Leu), and otoferlin C2F: GAGTACAAGATCGCTGCGCGGCTC, AGCCGCGCAGCGATCTTGTA (underlined nucleotides yield Ala, GCT, substituting for Pro). In the first step, each member of the mutated primer pair was coupled with the opposing downstream or upstream original C2D or C2F primer and otoferlin cDNA template to produce two smaller PCR products that each contained the mutated, complementary regions at one end. In the second step, the products were purified, mixed in equal proportion, and allowed to extend for three cycles of PCR, yielding full C2D or C2F mutated sequence. Additional original C2D or C2F upstream and downstream primers were added, and the reaction was continued. The resulting amplified products were purified and sequenced for verification of the single amino acid change, before cloning in pRSET vectors.
Expression of Hexahistidine Fusion Proteins −
pRSET vectors containing the desired sequences were used to transform E. coli BL21 (DE3) cells. Clones were selected, and expression of fusion proteins induced by adding 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) in LB culture medium. Cultures were incubated for 5 h at 37 °C. The cells were harvested, lysed in 10 mM phosphate buffer, 8 M urea, pH 7.4, centrifuged, and analyzed via 4-12% SDS-PAGE, with protein bands visualized by Coomassie blue staining. Clones that showed robust expression were selected and stored for future use. For purification of fusion proteins, 100-500-ml cultures of each clone were grown for 4-6 h, with protein expression induced by IPTG. The cells were harvested, lysed, centrifuged, and the clear supernatant passed through a Ni-NTA (nitrilo-triaceteic acid) nickel-affinity spin column (Qiagen). Columns were washed with wash buffer (10 mM phosphate, 8 M urea, pH 6.3) three times to remove non-specific components, and the affinity-bound proteins were eluted with elution buffer (10 mM phosphate, 8 M urea, pH 4.5). For thorough removal of urea, samples were diluted in an equal volume of PBST buffer and dialyzed extensively against PBST containing 1X protease inhibitors, with 5-6 buffer changes for 24 h at 4 ºC and constant stirring. At the end of the dialysis, the proteins were collected from the dialysis tubes and protein concentration determined with the Qubit fluorescent system (Invitrogen). Purity of the proteins was ascertained by SDS-PAGE with Coomassie blue staining and western immunoblotting using anti-His monoclonal antibody.
In an alternate procedure not involving urea, cells induced with IPTG were lysed by sonication, followed by centrifugation. The clear supernatant was mixed with 0.5 ml of Talon beads (Clontech). The beads were sedimented, washed, and the bound fusion proteins eluted by addition of elution buffer, followed by mixing and centrifugation. The supernatant containing the fusion proteins was then exhaustively dialyzed against cold PBST buffer containing 1X protease inhibitors.
Cloning of Syntaxin 1A and Ca v 1.3 II-III Loop in pGEX-6P-1 for Expression of GST-Fusion
Proteins − GST-fusion proteins were prepared for pull-down assay. PCR primers for syntaxin 1A and Ca v 1.3 II-III loop containing the desired restriction sites were used in PCR reactions to clone syntaxin and the calcium-channel domain in pGEX-6P-1 vector.
Expression of GST-Fusion Proteins − pGEX-6P-1 vectors containing syntaxin 1A or the Ca v 1.3 II-III loop were utilized to transform E. coli BL21 (DE3) cells. The clones were selected for expression of the fusion protein by IPTG induction. Bacterial cell lysates were either used directly in pull-down assays, or the fusion products were affinity-purified using Glutathione-Sepharose beads (GE HealthcareAmersham).
Yeast Two-hybrid Assays − Appropriate prey and bait vectors were used to co-transform yeast strain AH109 and were incubated in a lowstringency medium, SD/-Trp/-Leu, to select the double transformants. The colonies that grew were streaked onto a higher-stringency medium, SD/-Trp/-Leu/-His/-Ade, containing 3 mM 3-AT (3-amino-1,2,4-triazole), and grown for at least five days. Negative controls comprising empty bait or prey vectors were paired with vectors for their counterpart binding partners.
Pull-down Assay − Pull-down assays were performed using GST fusion proteins (GSTsyntaxin 1A and GST-Ca v 1.3 II-III loop) and hexahistidine-tagged fusion proteins (otoferlin C2 domains). GST-conjugates were mixed with hexahistidine-tagged C2 domains in binding buffer (PBST buffer, pH 7.4, 1X protease inhibitor cocktail) for 2 h at room temperature. GlutathioneSepharose beads (30 µl of a 50% slurry) were added to the reaction mix for 1 h at room temperature, followed by centrifugation for 2 min at 1,000 x g. The beads were washed five times in the binding buffer, incubated at 70 °C for 5 min in gel loading buffer (30 µl), and centrifuged. The supernatant was then electrophoresed in a 4-12% NuPAGE gel (Invitrogen), electroblotted to a nylon membrane, and immunodetected using anti-Xpress antibody.
Surface Plasmon Resonance Analysis − SPR was performed with a Biacore 3000 instrument. Affinity-purified fusion proteins were immobilized on a CM5 chip (research grade, Biacore, Piscataway, NJ, USA) by an amine-coupling reaction (16 (18) in the binding, 1:1 binding with mass transfer was chosen. The "residuals" (19) were checked and values with lowest χ 2 value selected. Residuals reflect the deviation of the actual binding from that of the model chosen, and were in the range of ±2 RU. Generally, we employed the global fitting method (20) , in which all the sensorgrams representing the different analyte concentrations were fitted simultaneously with the wide window of association and dissociation phases. Individual concentration by guest on May 3, 2016 http://www.jbc.org/ Downloaded from curves were also evaluated to confirm the fitting data.
Optical Analyses − For fluorometric analysis, 50 nM each of C2F and C2Fm in PBS (pH 7.4) were analyzed in a FluroMax-2 fluorometer (Jobin Yvon Inc., Edison, NJ, USA) with excitation at 282 nm, and the emission was recorded from 300-450 nm.
CD spectra were recorded with a Chirascan CD spectrometer (Applied Photophysics Ltd., Leatherhead, Surrey, UK) at 200 to 260 nm, using a 1-cm path-length cell. Samples were diluted in 1X PBS to yield a final concentration of 20 µM, and the PBS blank was subtracted from the sample.
Determination 
RESULTS

C2 Domains of Otoferlin.
Many isoforms of otoferlin, resulting from single amino-acid substitutions and truncations due to differential splicing (12) , are seen in DFNB9 patients (Fig. 1) . A short otoferlin isoform in humans contains only C2D, C2E, C2F, and the transmembrane domain. It is not yet clear whether the short form or the long form of the otoferlin transcript is expressed in the human cochlea, although there are indications that the long forms are functionally important (13) .
Otoferlin C2F Domain Directly Binds to Syntaxin 1A − In pilot studies (not illustrated), mouse otoferlin domains C2A, C2B, C2C, C2D, C2E, and C2F, cloned as bait in pGBKT7 vector, were tested in yeast strain AH 109 vs. syntaxin 1A fusion protein, which was cloned as prey in pGDAT7 vector. In SD/-Trp/-His/-Ade/-Leu medium containing 2 mM 3-AT, colonies that appeared represented syntaxin 1A interaction with C2A, C2B, and C2F. Few colonies were present when C2D and C2E were used as bait. When C2A, C2B, and C2F colonies were screened in a higherstringency medium containing 3 mM 3-AT, colonies appeared only for C2F ( Fig. 2A ) and C2A (not illustrated). There were no colonies on control plates where either bait or prey was substituted with empty vectors.
Otoferlin Domains Interact with Syntaxin 1A in
Pull-Down Assays − Pilot pull-down assays using GST-syntaxin 1A fusion protein and purified otoferlin-C2-domain His-tag fusion proteins showed that syntaxin 1A binds C2A, C2B, and C2E (not illustrated) as well as C2F (Fig. 2B , lane 3).
However, it is the C2F interaction that is strictly Ca 2+ -dependent (see below), unlike the interaction for C2A, C2B, and C2E where Ca 2+ is not absolutely required.
SPR Analysis of Otoferlin Domain-Syntaxin 1A
Interactions − Interaction of the six otoferlin C2 domains with syntaxin 1A was also examined with SPR, utilizing affinity-purified fusion proteins of the C2 domains as analytes and affinity-purified syntaxin 1A fusion protein immobilized on a CM5 sensor chip as ligand. The purified C2 domains were diluted to 200 nM concentration. The C2F domain distinctly bound syntaxin 1A in SPR analysis (Fig.  2C ). There was no binding when BSA was used as a negative control (Fig. 2C, (bar 7) . However, there was a drop of more than 50% in the binding when the Ca 2+ concentration was increased to 95 µM (bar 8), and there was no substantial decrease in binding when the level of Ca 2+ was further increased to 199 µM and 371 µM (bars 9-10). The results were normalized by subtracting the SPR response (RU) for buffer alone, and averaged from a single experiment performed in triplicate. All experiments were performed multiple times, and samples for different Ca 2+ concentrations were analyzed randomly. There was no binding to the reference cell surface, which was blocked by ethanolamine. Thus, the present data indicate that the C2F domain of otoferlin directly interacts with syntaxin 1A, this interaction requires free Ca 2+ optimally in the range of 44-61 µM, and there is no interaction if Ca 2+ is absent. The C2F domain is 98-100% conserved among the mammalian species shown in Table 1 , and would be expected to interact in a similar manner in other species, including human.
To test whether C2A binding was sensitive to Ca 2+ , the C2A domain was diluted to 200 nM in buffer containing either 61 µM free Ca 2+ or 3 mM EGTA, and analyzed by SPR (Fig. 2E) . There was little difference between the traces. Fig. 2F shows quantitatively that there was no significant difference in binding when free Ca 2+ was absent (with EGTA, bar 1) vs. present (bar 2). Thus it appears that the C2A interaction is insensitive to Ca 2+ , in contrast to the calcium sensitivity of the C2F interaction.
C2B and C2E domains, not requiring Ca 2+ for binding to syntaxin 1A in pull-down assays (above), exhibited relatively low SPR binding values, 35 and 14 RU, respectively (not illustrated).
A Pro1825Ala Substitution in the C2F Domain Abolishes C2F Ca 2+ -Binding Affinity − To explore how a single amino acid substitution in the C2F domain might correlate with non-syndromic deafness in humans (11), we produced the same amino acid substitution (Pro1825Ala) in mouse that is known to cause deafness in humans, by oligonucleotide-directed PCR-based alteration in C2F. The purified mutant C2Fm fusion protein showed no interaction with syntaxin 1A in SPR experiments (Fig. 3A, B) , in contrast to the prominent binding of native C2F to syntaxin 1A. Pull-down assays using GST-syntaxin 1A and C2F native and C2Fm mutated forms also demonstrated that the C2Fm does not interact with syntaxin 1A (Fig. 3C ). The position of the Pro1825Ala mutation in C2F lies between the strands 6 and 7 (β sheet) of the secondary structure (Fig. 3D) , with proline demarking a probable bend in the polypeptide chain for native C2F.
Calcium Binding of the C2F Domain − The intrinsic fluorescence of the C2F domain (contributed by Trp and other aromatic amino acids, Fig. 3D ) was markedly elevated with Ca 2+ for native but not the mutated form. Fig. 3E (mutated form) and 3F (native form) show emission spectra in the presence of 61 µM free Ca 2+ (solid traces), and emission in the absence of Ca 2+ (1mM EGTA) by the dashed traces. Fig. 3E shows that the C2Fm solution does not exhibit any increase in fluorescence in the presence of 61 µM free Ca 2+ compared to the absence of free Ca 2+ . However, for the native C2F domain, emission is clearly increased by the addition of Ca 2+ to a 61 µM free Ca 2+ concentration (Fig. 3F , solid trace). This effect was reversed by 2 mM EGTA (dashed trace). In order to test whether the native state of C2 fusion protein was maintained after purification with urea-containing buffers followed by dialysis (see Experimental Procedures), we analyzed with circular dichroism the C2F-domain fusion protein prepared under denaturing vs. non-denaturing conditions (Fig. 3G) . The CD spectra proved similar, suggesting that fusion proteins such as C2F extracted with urea, after exhaustive dialysis against non-denaturing buffers, were properly re-folded in the present studies. The spectra show a broad minimum at 206-207 nm as well as a tendency for a minimum in the 221-222 nm region. The spectral trace was flat above 240 nm and increased below 205 nm (Fig. 3G) (Fig. 5A) . In general, the number of colonies that developed on the selection plate indicated the strength of the interaction. Although we also detected interaction of Ca v 1.3 with the C2A, C2B, and C2F domains, the latter interactions were clearly weaker (not shown). Otoferlin C2D-Ca v 1.3 II-III loop interaction was also demonstrated in pull-down assays, where native C2D bound the GST-Ca v 1.3 II-III loop, yielding a prominent band on western blot (Fig. 5B, lane 4) . In contrast, the mutated C2Dm did not bind the GSTCa v 1.3 II-III loop (Fig. 5B, lane 3) .
The affinity-purified fusion proteins of the otoferlin C2 domains were further analyzed for interaction with the purified Ca v 1.3 II-III loop using SPR. C2 domains (250 nM) in HBS-EP binding buffer were employed as analytes. C2D showed the maximum response (Fig. 5C, upper trace) , whereas other C2 domains (not illustrated) yielded much lower interaction responses; C2F produced 60, C2B 35, C2A 30, and C2C 10 RU, while C2E did not bind. There was no response when 1 mM BSA was used as a negative control. Using a mouse mutant C2Dm fusion protein with an amino acid substitution (Leu1011Pro; 1010 in mouse) identical (Fig. 5C, lower Fig. 5D , dotted bars). There was no substantial binding with zero free Ca 2+ (Fig. 5D, dotted bar 1 (Fig. 6A) , we analyzed the binding of otoferlin domains C2F (and C2D, not illustrated) at 0, 25, 50, 75, and 100 nM concentrations, with SPR. Fig. 6A shows the set of data for varying concentrations of C2F samples containing 61 µM Ca 2+ . There was no mass transfer limitation (17) in the interaction, as determined by analyzing 40 nM C2F at several flow rates (5, 15, and 75 µl/min). Using BIAevaluation software (GE Healthcare-Amersham), the curves for the above concentrations of C2F (and C2D) were globally fit to a 1:1 Langmuir binding model to determine the rate constants and equilibrium constants. For global fitting we achieved a χ 2 value of 2.1, whereas for individual curves we obtained values less than 1.0. (low χ 2 values indicate closeness of the actual values to the model chosen.) The equilibrium dissociation constants for syntaxin 1A-C2F vs. syntaxin 1A-C2D binding (Table 2 ; data from individual curves) suggested weaker interaction for the latter binding couple. A similar experiment with 1 mM EGTA in the binding buffer and the same set of C2F concentrations as above resulted in no binding of C2F to syntaxin 1A.
SNAP-25-C2F
Binding Kinetics − Using SNAP-25 as ligand in SPR analyses, we also examined the binding for 0, 40, 80, 160, and 320 nM concentrations of otoferlin C2F containing 61 µM Ca 2+ (Fig. 6B) . Again, there was no significant mass transfer limitation. Kinetic constants were determined as for Fig. 6A . With global fitting, we achieved a χ 2 value of 6.8, whereas for individual curves we obtained values less than 3.0. The equilibrium constant for dissociation of the SNAP-25-C2F interaction was determined to be 1.7 x 10 -7 M ( Table 2) .
Ca v 1.3-C2D
Binding Kinetics − The II-III loop of the L-type voltage gated calcium channel Ca v 1.3 was used as the ligand in further SPR experiments to determine the binding kinetics for the otoferlin C2D domain (Fig. 6C) . Kinetic constants were evaluated as above. A value of 1.4 x 10 -7 M for the dissociation equilibrium constant for Ca v 1.3-C2D domain interaction was obtained ( Table 2) . sensor of the hair cell synapse. Mouse knockouts for the OTOF gene are deaf and show no exocytosis from the inner hair cells (14) . In human, a number of OTOF gene mutations cause either truncation of the protein (10,13) or single amino-acid substitutions in C2F (11), C2D (12), or C2C (24) (cf. Fig. 1 ). In the present study, we chose two functionally-important amino-acid substitutions, one in C2F and one in C2D, in order to investigate how these domains may individually interact with the proteins involved in synaptic-vesicle fusion in the hair cell.
DISCUSSION
Otoferlin as a SNARE-binding Ca
Ca 2+ Dependency of Otoferlin C2 Domain
Interactions − Our results demonstrated that otoferlin interacts with the t-SNARE synaptic proteins syntaxin 1A and SNAP-25, and that this interaction requires free Ca 2+ , as is the case for the Ca 2+ sensor synaptotagmin 1 which mediates neuronal exocytosis (25) . However, otoferlin may also interact with syntaxin 1A in a Ca 2+ -independent manner for certain C2 domains. For example, our binding results involving the C2A domain and syntaxin 1A show that Ca 2+ is not necessary for the C2A interaction, suggesting that C2A is unlikely to contribute directly to the Ca 2+ -sensitive exocytosis at the mammalian hair cell synapse. Moreover, our work involving the C2F domain interaction with syntaxin 1A or SNAP-25 shows that optimal binding is attained when the free Ca 2+ concentration reaches 61 µM, but that binding decreases when the Ca 2+ concentration is increased further. The latter finding differs from the results of an earlier report (14) , where the strength of binding of syntaxin 1A to an otoferlin polypeptide containing the complete stretch of C2D, C2E, and C2F domains regularly increased up to 1 mM Ca 2+ , with a calculated halfmaximal effective concentration of 80 µM. This apparent discrepancy might be explained by the fact that we examined solely the otoferlin C2F domain, whereas the previous study (14) (27) , which would be in accord with our Ca 2+ -dependency results for binding between C2F and syntaxin 1A and SNAP-25. The mechanism for the decreased binding we observe at the higher Ca 2+ concentrations is currently unknown, but may be due to electrostatic properties of divalent cations such as Ca 2+ (28) , that can change the molecular electrostatic environment, leading to the reduced binding.
C2F as the Main Otoferlin C2 Domain
Interacting with Vesicular Proteins − We found that the Pro1825Ala mutation in the C2F domain almost completely abolished C2F interaction with the SNARE proteins examined in the current study. Prediction of secondary structure for C2F shows that the proline residue undergoing mutation is situated between β strands 6 and 7 ( Fig. 3D ; strands numbered according to C2 "type II" topology) (22, 29, 30) , a location that is near the presumptive Ca 2+ -binding region in the molecule. Although the actual residues responsible for binding Ca 2+ in many C2 domains, such as C2F, cannot be known with certainty, due to the paucity of crystallographic data, the four acidic residues highlighted in the otoferlin C2F sequence (Fig. 3D) represent a reasonable assignment of the coordination sites, reflecting the spacing of amino acids suggested by a consensus line-up of 65 different C2 sequences (22) . One-to-two Ca 2+ ions are thought to bind at the edge of a β-sandwich, in a concave depression formed by the two extended loops between β strands 1 and 2 and β strands 5 and 6 (30) Fig. 3E and 3F illustrate the behavior of tryptophan fluorescence spectra for purified C2Fm and native C2F fusion proteins in the presence and absence of Ca 2+ . Significantly, the mutated C2Fm domain (Fig. 3E) is insensitive to Ca 2+ , compared to the native C2F (Fig. 3F) . Calcium-binding aspartate and glutamate residues (Fig. 3D, highlighted) in the C2 domains are separated from one another in the C2 primary structure. Calcium enhancement of tryptophan fluorescence is possible only if the C2 domain folds correctly, positioning the tryptophan (underlined) and carboxylic residues located in the different loops. Proper clustering of tryptophancontaining loops increases the tryptophan fluorescence. Our results for the mutated C2Fm show that even though there is tryptophan fluorescence, addition of calcium does not increase the fluorescence intensity (Fig. 3E) , suggesting that the C2Fm does not fold properly to bind Ca 2+ and thus change the tertiary structure appropriately. In addition to the C2F domain, the C2D domain showed Ca 2+ -dependent enhancement of fluorescence in the presence of Ca
2+
(not illustrated).
The fact that Ca 2+ -dependent enhancement of the tryptophan-based fluorescence clearly occurred for the purified fusion proteins in the current investigation, in addition to the occurrence of overlapping CD spectra corresponding to the different isolation methods (Fig. 3G) , marshals evidence that the proteins were able to refold to native configuration during our isolation procedures. The CD spectra of Fig. 3G are, in fact, consistent with the presence of C2F secondary structure, as predicted in Fig. 3D . The Fig. 3G plot can be interpreted as a sum of spectra for β sheet and α helix (31) . There is clearly no shift of minimum to values below 200 nm that would indicate denaturation (32) .
Although not examined, it is possible that an additional degree of molecular organization would be introduced by the interaction of otoferlin C2 domains with the synaptic complex proteins. The phenomenon of induced secondary-structural order (33, 34) may be relevant to the association of C2 domains with their binding partners, suggesting future studies.
It can be inferred that the C2F domain is the main calcium sensing module within otoferlin that directly interacts with SNARE proteins. Even though there might be cooperativity among the C2 domains, each C2 domain may have a specific and independent role in the exocytotic process. It should also be noted that the in vitro studies reported here do not consider the complexity of the lipid environment, which has been shown to support Ca 2+ dependency of exocytosis in the case of synaptotagmin 1 (6).
C2 Domain Binding Affinity − Another important factor for exocytosis could be the differential C2-domain binding affinity for the SNARE proteins. Each C2 domain of otoferlin may have a different affinity, in terms of rate as well as equilibrium constant, dictating which C2 domain or domains might bind more avidly and rapidly to initiate Ca 2+ -triggered vesicle docking and exocytosis.
For example, in our study, we compared the C2D and C2F affinity for syntaxin 1A and found that the C2F binds syntaxin more strongly than does C2D (Table 2) .
C2D Domain Interaction with the L-type
Calcium Channel Ca v 1.3 − It is known that synaptotagmin 1, the presumed calcium-sensing counterpart of otoferlin in neurons, directly interacts with and modulates voltage-gated calcium channels (35) . In the present work, we found that otoferlin through its C2D domain binds to the II-III cytoplasmic loop of Ca v 1.3, which is the major Ltype calcium channel in mammalian hair cells (9) . We also found that this interaction is regulated by Ca 2+ , and that a maximum of 61 µM Ca 2+ is required for optimal binding under in vitro conditions. Moreover, a mutation (Leu1011Pro) that causes deafness in humans (12) diminishes the C2D binding to Ca v 1.3 almost three-fold, and the C2D mutant is insensitive to Ca 2+ .
Although our evidence suggests that, of the otoferlin C2 domains, C2D binds the Cav1.3 II-III loop with the highest affinity, other C2 domains may also be involved. It is beyond the scope of the present investigation to measure all interactions (most of them significantly weaker) of the otoferlin domains − Ca 2+ -dependent and -independent − with the calcium channel and SNARE proteins. Several published studies describe Ca 2+ -dependent and independent binding of synaptotagmin to syntaxin. Kee and Scheller (36) showed that synaptotagmin binding to syntaxin 1A increases as the calcium concentration increases. The latter paper also describes changes in the calcium-dependent binding when portions of the synaptotagmin protein are deleted. One such syntaxin mutant, syt1-5, showed calcium-independent binding, as well as a decrease in binding in response to an increase in calcium concentration.
In summary, our study shows that individual otoferlin C2 domains may act independently of each other in the exocytotic process. Otoferlin, through C2 domains, binds two key SNARE synaptic proteins of hair cells, syntaxin 1A and SNAP-25. Otoferlin directly interacts with syntaxin 1A via the C2F domain. A mutation in C2F diminishes its Ca 2+ -binding ability as well as its interaction with syntaxin 1A. SNAP-25, another t-SNARE protein, also interacts with the C2F domain. We further find that the C2D domain of otoferlin interacts with the calcium channel Ca v 1.3 in a calcium-dependent manner, and that a mutation in C2D leads to a substantially decreased binding to Ca v 1.3, independent of calcium. Thus otoferlin, through its C2 domains, may be an important contributor to Ca 2+ -dependent synaptic transmission in hair cells. Fig. 1 . Diagram illustrating predicted structure of the otoferlin protein (GenBank AF183186, human). The SMART program (EMBL-Heidelberg, Germany) was used to predict the six C2 domains, A (residues 2-97), B (255-353), C (418-529), D (961-1068), E (1493-1592), F (1733-1863), and the carboxy terminal transmembrane region, TM . Large arrowheads indicate the positions of two mutations that were the focus of the present study, in domains C2D (1011 human; 1010 mouse) and C2F (1825). Four thick arrows relate to other single amino-acid substitutions known to cause deafness (left to right): Pro490Gln, Ile515Thr, Arg1939Gln, and Pro1987Arg (12, 13) . Thin arrows correspond to points of truncation: Arg237, Glu551, Arg708, Gln829, Trp1425, and Tyr1497 (12) . Mouse otoferlin sequence (NM_031875) is 98% identical to human sequence and exactly the same length (1997 aa). (21) program. Otoferlin C2F exhibits type II C2 topology (30) , with seven strands of predicted β structure (strands 1-7, arrows and lines above sequence), one strand of predicted helical structure (strand 8), and intervening loops of extended (random coil) structure (21) . Tryptophan residues that might increase intrinsic fluorescence of C2F when folded correctly are underlined. Letters at Pro-Ala mutation site (thought to reduce Ca 2+ affinity of otoferlin C2F) are bolded. Four carboxylic amino-acid residues, positioned to possibly coordinate Ca 2+ binding (22) , are highlighted in gray, and other nearby carboxylic residues are dotted. Predictions for turns in the secondary structure are marked by ~ and bends by ^. Lowest line shows consensus amino acids with identity of 50% or more, as derived from sequence alignment of 65 different C2 domains (22) , with hyphens indicating non-consensus residues. E. Normalized fluorescence spectra for affinity-purified C2Fm domain. The Pro-Ala mutated C2Fm domain protein (20 µM concentration) is insensitive to Ca 2+ , with no difference in the fluorescence spectrum between conditions of 61 µM Ca 2+ (solid trace) and EGTA (dashed trace). F. Normalized fluorescence spectra for affinity-purified native C2F domain. When 61 µM Ca 2+ is added to the native C2F protein solution (20 µM), the fluorescence is considerably elevated (solid trace), compared to lowered fluorescence for the same solution with added 2 mM EGTA (dashed trace). G. Circular dichroism spectral analysis of the C2F domain fusion proteins purified with urea buffer followed by dialysis against PBST buffer (thick trace; see text) vs. CD spectrum for C2F purified under non-denaturing conditions, in PBST (dashed trace). Fig. 4. SNAP-25-C2F interaction. A. SPR analysis of C2F and C2Fm interaction with SNAP-25. Purified C2F and C2Fm fusion peptides (100 nM) were injected as analytes. B. Ca 2+ -sensitivity of C2F binding to SNAP-25. SNAP-25 was immobilized as ligand and C2F domain fusion peptide (100 nM) served as analyte in buffer representing a series of free Ca 2+ concentrations. Bars 1-10 represent, respectively, 0 (i.e., 3 mM EGTA), 30, 33, 37, 40, 44, 61, 95, 199 , and 371 µM Ca 2+ . Each bar shows the maximum binding (RU) obtained. Table 2 ). A. Syntaxin 1A interaction with the otoferlin C2F domain. Purified syntaxin 1A was immobilized on a CM5 sensor chip and C2F was diluted in a series of concentrations (0, 25, 50, 75, and 100 nM, bottom to top). Curves were selected and fit using a global fitting method and a 1:1 Langmuir binding model (not illustrated) with drifting baseline (17) . Deviation of fit from model, along the curves, is indicated by the "residual" (RES) plots for association (0-300 s) and dissociation (300-650 s). B. SNAP-25 interaction with the otoferlin C2F domain. Curves represent C2F concentrations of 0, 40, 80, 160, and 320 nM, evaluated as in A. C. Ca v 1.3 II-III loop interaction with the otoferlin C2D domain. The purified Ca v 1.3 II-III loop fusion protein was immobilized as before, and C2D analyte was tested for interaction at 0, 75, 150, 300, and 600 nM concentrations. Amino acid sequences from vertebrate classes were analyzed to identify the C2 domains using the Simple Modular Architecture Research Tool (SMART, EMBL-Heidelberg, Germany). The predicted C2 domains were aligned against the corresponding predicted mouse C2 domains. The amino acid identity for each was determined by the BLAST program (NCBI, Bethesda, MD). The percent identity of each C2 domain above is referenced to the corresponding mouse sequence. GenBank accession numbers (protein) are listed in parenthesis. 
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Each association and dissociation value was determined from 5 different concentrations.
by guest on May 3, 2016 
